Results 191 to 200 of about 114,153 (288)

TDM. From the standpoint of clinicians. 2. TDM of antiepileptics or lithium.

Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1988
openaire   +3 more sources

A hybrid metaheuristic framework for robust photovoltaic model parameter estimation based on crested porcupine and differential evolution algorithms. [PDF]

Sci Rep
Mohamed AAH, Diaaeldin IM, Attia MA, Helmy W.   +3 more
europepmc   +1 more source

Polarization‐resolved femtosecond Vis/IR spectroscopy tailored for resolving weak signals in biological samples using minimal sample volume

FEBS Open Bio, Volume 16, Issue 10, Page 1847-1856, October 2026.
Unique biological samples, such as site‐specific mutant proteins, are available only in limited quantities. Here, we present a polarization‐resolved transient infrared spectroscopy setup with referencing to improve signal‐to‐noise tailored towards tracing small signals. We provide an overview of characterizing the excitation conditions for polarization‐
Clark Zahn, Karsten Heyne
wiley   +1 more source

Guideline-informed vancomycin therapeutic drug monitoring indications in an adult intensive care unit: a retrospective descriptive study. [PDF]

BMC Anesthesiol
Ayhan YE, Sarı Küçük R, Özkan AN, Akay Gedi̇k H, Şi̇mşek F, Bektay MY.   +5 more
europepmc   +1 more source

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

Arthritis Care &Research, Volume 78, Issue 10, Page 1424-1437, October 2026.
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh, Dalia Sriwi, Callie Saric, Tripti Singh, Christie M. Bartels, Shivani Garg   +5 more
wiley   +1 more source

Switching Between Anti-TNFs and Other Biologic Drugs in Paediatric Inflammatory Bowel Disease: A Narrative Review and Practical Clinical Guide. [PDF]

J Inflamm Res
Romano A, Vazzana GF, Romano C.
europepmc   +1 more source

Intelligent Distributed Optical Fiber Sensing in Transportation Infrastructures: Research Progress, Applications, and Challenges

Advanced Photonics Research, Volume 7, Issue 10, October 2026.
Distributed optical fiber sensing (DOFS) is reviewed as a transformative technology for intelligent monitoring of transportation infrastructures. Advances in sensing fibers, cable design, and data analytics are summarized alongside representative field applications.
Xin Gui, Fanhao Zeng, Yunchuan Zhang, Yiming Wang, Jiaqi Wang, Changjia Wang, Xuelei Fu, Sheng Li, Fang Liu, Lina Yue, Jinpeng Jiang, Zhengying Li   +11 more
wiley   +1 more source

Bridging the Gap Between Chemiluminescence Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry for Infliximab Monitoring: Method Validation and Clinical Comparability Study. [PDF]

J Sep Sci
Xia Y, Zhu MM, Xiao MQ, Zhong CC, Zhou YJ, Xue YH, Zheng SW, Li L, Chen F.   +8 more
europepmc   +1 more source

Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients

British Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3375-3386, October 2026.
Aim Imatinib pharmacokinetics exhibit large interindividual variability because of differences in CYP3A4 activity—the main imatinib‐metabolizing enzyme. While therapeutic drug monitoring is effective, it requires steady‐state conditions and frequent sampling.
Anna Sofie Buhl Rasmussen, Mathilde Rønne Koch, Cecilie Utke Rank, Christen Lykkegaard Andersen, Allan Weimann, Maria Thastrup, Tianwu Yang, Trine Meldgaard Lund, Ib Jarle Christensen, Flemming Nielsen, Tore Bjerregaard Stage, Sara Bisgaard Jensen, Mette Klarskov Andersen, Kjeld Schmiegelow, Kim Dalhoff   +14 more
wiley   +1 more source

Next-generation hybrid bioanalytical platforms and clinical integration of TDM technologies for precision monitoring to optimize last-resort antibiotic therapy. [PDF]

Front Pharmacol
Inamdar A, Beeraka NM, Hemanth Vikram PR, Gurupadayya B, Sanathan SR, Prashant A, Kumar TP, Nikolenko VN, Padmanabha Reddy Y, Kandula DR, Basappa B.   +10 more
europepmc   +1 more source